Alunbrig is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Ariad Pharmaceuticals Inc.. The primary component is Brigatinib.
| Product ID | 76189-113_76928450-348f-4d49-b086-17866cfb34c6 |
| NDC | 76189-113 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Alunbrig |
| Generic Name | Brigatinib |
| Dosage Form | Tablet, Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-04-28 |
| Marketing End Date | 2020-12-12 |
| Marketing Category | NDA / NDA |
| Application Number | NDA208772 |
| Labeler Name | ARIAD Pharmaceuticals Inc. |
| Substance Name | BRIGATINIB |
| Active Ingredient Strength | 30 mg/1 |
| Pharm Classes | Kinase Inhibitor [EPC],Tyrosine Kinase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA] |
| NDC Exclude Flag | N |
| Marketing Start Date | 2017-04-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA208772 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-04-28 |
| Marketing End Date | 2020-12-12 |
| Marketing Category | NDA |
| Application Number | NDA208772 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-04-28 |
| Marketing End Date | 2020-12-12 |
| Ingredient | Strength |
|---|---|
| BRIGATINIB | 30 mg/1 |
| SPL SET ID: | 07b71b73-1ca3-4e78-a787-e458917f1f23 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 63020-090 | Alunbrig | brigatinib |
| 63020-113 | Alunbrig | brigatinib |
| 63020-180 | Alunbrig | brigatinib |
| 63020-198 | Alunbrig | brigatinib |
| 76189-113 | Alunbrig | Brigatinib |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ALUNBRIG 86797024 5251769 Live/Registered |
ARIAD Pharmaceuticals, Inc. 2015-10-23 |